Pfizer Pharmaceutical Company

Alnylam Pharmaceuticals, Pfizer

Alnylam Expanded Heart Drug Approval Sets Up Pfizer Challenge

Alnylam Pharmaceuticals Inc. won expanded US approval for a heart drug that could be the biggest boon yet for the 23-year-old biotech — if it can beat out stiff competition from the likes of Pfizer Inc.

Fierce Pharma · 14h

Alnylam's Amvuttra wins key approval in ATTR-CM, teeing up showdown with Pfizer

Despite growing competition in the transthyretin amyloid cardiomyopathy (ATTR-CM) field, Alnylam is hoping its RNA interference approach can set it apart from its peers. | Despite growing competition in the transthyretin amyloid cardiomyopathy (ATTR-CM) field,

The Business Journals · 15h

Alnylam wins FDA approval for rare heart disease drug

Alnylam Pharmaceuticals Inc. won a major FDA approval on Thursday, one that could propel the Cambridge company toward a major milestone — finally reaching profitability.

STAT14h

Pfizer’s Wall Street critic-turned-executive digs into the company’s problems, obesity plans

Andrew Baum, Pfizer's chief strategy and innovation officer, talked Thursday about the pharmaceutical company's drug ...

2don MSN

Pfizer to sell entire Haleon stake

Pfizer will sell its remaining stake in British consumer healthcare group Haleon , the companies said on Tuesday.

1don MSN

2 High-Yield Dividend Stocks That Are Bargain Buys Right Now

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

5PFE : 4 Analysts Assess Pfizer: What You Need To Know

Pfizer PFE underwent analysis by 4 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.

14d

Pfizer Vs. Johnson & Johnson: Who's The Better Bargain For Investors

Discover the strengths & weaknesses of healthcare giants Johnson & Johnson and Pfizer. Find out which stock is more promising ...

STAT16d

Pharmalittle: We’re reading about Pfizer navigating tariffs, Makary’s pledge to avoid conflicts, and more

Pfizer CEO Albert Bourla said the drugmaker might move overseas manufacturing to its plants in the U.S. as Trump threatens import tariffs ...

Yahoo Finance26d

Pfizer Inc. (PFE): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts

In this article, we are going to take a look at where Pfizer Inc. (NYSE ... and medical technology. Pharmaceutical companies in particular have received much attention as the demand for speedy ...

Trump rags Irish prime minister on trade as 25% tariffs on EU steel, aluminum take effect: ‘Take back the wealth’

WASHINGTON — The craic wasn’t all good at the White House Wednesday, as President Trump hosted Irish Prime Minister Micheál ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results